James Cheng‐Chung Wei

24.4k total citations · 5 hit papers
581 papers, 12.4k citations indexed

About

James Cheng‐Chung Wei is a scholar working on Rheumatology, Immunology and Epidemiology. According to data from OpenAlex, James Cheng‐Chung Wei has authored 581 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 188 papers in Rheumatology, 97 papers in Immunology and 67 papers in Epidemiology. Recurrent topics in James Cheng‐Chung Wei's work include Spondyloarthritis Studies and Treatments (102 papers), Rheumatoid Arthritis Research and Therapies (91 papers) and Psoriasis: Treatment and Pathogenesis (57 papers). James Cheng‐Chung Wei is often cited by papers focused on Spondyloarthritis Studies and Treatments (102 papers), Rheumatoid Arthritis Research and Therapies (91 papers) and Psoriasis: Treatment and Pathogenesis (57 papers). James Cheng‐Chung Wei collaborates with scholars based in Taiwan, United States and China. James Cheng‐Chung Wei's co-authors include Nan Yao, Vincenzo Lordi, Shiow‐Ing Wang, Yu‐Hsun Wang, Fu‐Shun Yen, Joachim Sieper, Jing‐Yang Huang, Yao‐Min Hung, Chii‐Min Hwu and Chrysanthos E. Gounaris and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Chemical Physics and SHILAP Revista de lepidopterología.

In The Last Decade

James Cheng‐Chung Wei

549 papers receiving 12.0k citations

Hit Papers

The Assessment of Spondyl... 1992 2026 2003 2014 2010 1992 2017 2022 2023 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
    2010 1.1k citations James Cheng‐Chung Wei et al. Annals of the Rheumatic Diseases profile →
  2. Diffusion mechanism of hydrocarbons in zeolites—I. Theory
    1992 409 citations James Cheng‐Chung Wei et al. profile →
  3. Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study
    2017 272 citations James Cheng‐Chung Wei et al. Annals of the Rheumatic Diseases profile →
  4. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks
    2022 216 citations Shiow‐Ing Wang, James Cheng‐Chung Wei et al. profile →
  5. Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study
    2023 159 citations Renin Chang, Shiow‐Ing Wang et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
James Cheng‐Chung Wei 3.9k 2.5k 1.5k 1.4k 1.3k 581 12.4k
Karel Pavelká 10.8k 2.7× 3.7k 1.5× 3.7k 2.5× 2.6k 1.8× 504 0.4× 374 19.7k
Eun‐Kyung Kim 730 0.2× 2.1k 0.9× 346 0.2× 3.5k 2.5× 1.3k 1.0× 1.1k 27.1k
Matthias Schwab 695 0.2× 2.1k 0.8× 989 0.7× 8.6k 6.2× 7.9k 5.9× 792 45.9k
W. Robert Lee 1.2k 0.3× 1.0k 0.4× 383 0.3× 5.4k 3.8× 763 0.6× 799 24.9k
Takao Saito 1.0k 0.3× 492 0.2× 230 0.2× 3.9k 2.8× 703 0.5× 638 14.1k
Kun Wang 421 0.1× 2.4k 1.0× 383 0.3× 7.8k 5.6× 2.2k 1.6× 865 23.4k
Angelo Vacca 884 0.2× 3.4k 1.4× 5.4k 3.6× 9.9k 7.1× 1.6k 1.2× 494 22.9k
Jiaquan Xu 669 0.2× 1.8k 0.7× 649 0.4× 10.4k 7.4× 1.1k 0.8× 129 35.2k
Yukio Miki 994 0.3× 629 0.3× 180 0.1× 1.5k 1.1× 393 0.3× 526 9.9k
Zuo‐Feng Zhang 768 0.2× 945 0.4× 253 0.2× 9.2k 6.5× 1.7k 1.3× 680 29.7k

Countries citing papers authored by James Cheng‐Chung Wei

Since Specialization
Citations

This map shows the geographic impact of James Cheng‐Chung Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Cheng‐Chung Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Cheng‐Chung Wei more than expected).

Fields of papers citing papers by James Cheng‐Chung Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Cheng‐Chung Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Cheng‐Chung Wei. The network helps show where James Cheng‐Chung Wei may publish in the future.

Co-authorship network of co-authors of James Cheng‐Chung Wei

This figure shows the co-authorship network connecting the top 25 collaborators of James Cheng‐Chung Wei. A scholar is included among the top collaborators of James Cheng‐Chung Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Cheng‐Chung Wei. James Cheng‐Chung Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gau, Shuo‐Yan, Chih‐Wei Chen, Yu‐Hsun Wang, Ching‐Chi Chi, & James Cheng‐Chung Wei. (2025). Increased risk of incident alopecia areata among patients with hidradenitis suppurativa: A multicenter cohort study in the United States. Biomedical Journal. 48(3). 100837–100837.
2.
3.
4.
Yen, Fu‐Shun, et al.. (2024). Impact of family income on the development of gestational diabetes mellitus and the associated birth outcomes: A nationwide study. Journal of Diabetes Investigation. 16(1). 51–59. 2 indexed citations
5.
Chen, Yuping, et al.. (2024). Risk factors for cerebral palsy in children in Taiwan. Developmental Medicine & Child Neurology. 66(8). 1062–1073. 1 indexed citations
6.
Huang, Jing‐Yang, et al.. (2024). Maternal human papillomavirus infection and the risk of congenital malformations: A nationwide population‐based cohort study. Journal of Medical Virology. 96(4). e29549–e29549.
7.
8.
Wu, Yu‐Chien, Tzu-Yu Liu, James Cheng‐Chung Wei, et al.. (2024). Verbal training can improve neurocognitive and reading performance by increasing white matter integrity and grey matter volume. Experimental Gerontology. 198. 112625–112625. 2 indexed citations
9.
Yen, Fu‐Shun, et al.. (2024). Microvascular disease and its association with dementia in patients with type 2 diabetes: A nationwide cohort study in Taiwan. Diabetes Obesity and Metabolism. 26(11). 5399–5407. 2 indexed citations
10.
Wei, James Cheng‐Chung, Shih‐Hui Huang, Chun‐Yu Chen, et al.. (2024). Risks of Kawasaki disease and multisystem inflammatory syndrome in pediatric patients with COVID-19 infection: A TriNetX based cohort study. Journal of the Chinese Medical Association. 87(9). 861–869. 1 indexed citations
11.
Wang, Yu‐Hsun, Chun‐Ju Lin, Ning‐Yi Hsia, et al.. (2024). Assessing Uveitis Risk following Pediatric Down Syndrome Diagnosis: A TriNetX Database Study. Medicina. 60(5). 710–710.
12.
Wei, James Cheng‐Chung, Roy Fleischmann, Shannon R. Morris, et al.. (2023). OP0295 A 12-WEEK, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE 2B STUDY OF SAFETY, TOLERABILITY AND EFFICACY OF AR882 IN GOUT PATIENTS. Annals of the Rheumatic Diseases. 82. 192–192. 5 indexed citations
13.
Ou, Shih‐Hsiang, et al.. (2023). Diabetic Macular Edema Is Predictive of Renal Failure in Patients With Diabetes Mellitus and Chronic Kidney Disease. The Journal of Clinical Endocrinology & Metabolism. 109(3). 761–770. 2 indexed citations
14.
Yen, Fu‐Shun, Shiow‐Ing Wang, Shih‐Yi Lin, & James Cheng‐Chung Wei. (2023). Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 200. 110692–110692. 5 indexed citations
15.
Yen, Fu‐Shun, et al.. (2023). Maternal autoimmune disease associated with a higher risk of offspring with type 1 diabetes: A nationwide mother-child cohort study in Taiwan. Diabetes & Metabolism. 49(3). 101443–101443. 3 indexed citations
16.
Leong, Pui‐Ying, et al.. (2022). Increased risk of being diagnosed with endometriosis in patients with Systemic lupus erythematosus: a population-based cohort study in Taiwan. Scientific Reports. 12(1). 13336–13336. 5 indexed citations
17.
Wang, Yu‐Hsun, et al.. (2021). Associations of Chinese Herbal Medicine Usage with Risk of Dementia in Patients with Parkinson's Disease: A Population-Based, Nested Case–Control Study. The Journal of Alternative and Complementary Medicine. 27(7). 606–612. 3 indexed citations
18.
Sheng‐Kai, Kevin, et al.. (2021). Onset of oral lichen planus following dental treatments: A nested case–control study. Oral Diseases. 29(3). 1269–1281. 13 indexed citations
19.
Yong, Su‐Boon, et al.. (2018). Impact of chronic urticaria on systemic lupus erythematosus: A nationwide population‐based study in Taiwan. The Journal of Dermatology. 46(1). 26–32. 8 indexed citations
20.
Wei, James Cheng‐Chung, et al.. (1964). On global representations of the solutions of linear differential equations as a product of exponentials. Proceedings of the American Mathematical Society. 15(2). 327–334. 250 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karel Pavelká Breakdown of academic impact, for papers by Eun‐Kyung Kim Breakdown of academic impact, for papers by Matthias Schwab Breakdown of academic impact, for papers by W. Robert Lee Breakdown of academic impact, for papers by Takao Saito Breakdown of academic impact, for papers by Kun Wang Breakdown of academic impact, for papers by Angelo Vacca Breakdown of academic impact, for papers by Jiaquan Xu Breakdown of academic impact, for papers by Yukio Miki Breakdown of academic impact, for papers by Zuo‐Feng Zhang
Rankless by CCL
2026